Swept Source OCT Imaging With the DREAM VG-OCT

Robert T. Chang, MD154 enrolled

Overview

The Intalight Dream OCT is the first combo anterior plus posterior device to perform both OCT and OCT-A at depth of 16mm. This is especially useful in patient who are very nearsighted as it allows us to image all in one frame. The intention of this study is to see how the images differ on the same patients when compared to the Cirrus OCT and to test for the repeatability of the images on a single day.

Study Type

OBSERVATIONAL

Enrollment

154

Conditions

Eye Diseases Myopia Glaucoma

Interventions

DREAM OCTDEVICE

Swept Source OCT (similar to Zeiss Plex Elite)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age greater than or equal to 18 * Myopes with a current or previously documented spherical equivalent refraction \< -4D * At least half of the subjects should have had at least one Cirrus OCT RNFL and macula performed as well as a Humphrey visual field performed in those with OCT abnormalities Exclusion Criteria: * Unable to comply with study imaging * unclear ocular media * Participant has, in the opinion of the investigator, any physical or mental condition that would affect the participation in the study or may interfere with the study procedures, evaluations and outcome assessments.

Locations (1)

Byers Eye Institute

Palo Alto, California, United States

Outcomes

Primary Outcomes

Assessing difference in intraocular structures

Assessing the performance of the DREAM VG OCT scan patterns in high myopes including glaucomatous eyes to see if there are differences in the lamina cribrosa structure when compared to patients previous Cirrus OCTs.

Time frame: Baseline

Assessing difference in intraocular vascular structures

Assessing differences in vascular density in areas with presumed myopic-related field defects vs. low tension glaucoma perimetric disease

Time frame: Baseline

Secondary Outcomes

Assessing repeatability of scans

Analyze the repeatability of quantitative RNFL and GCC parameters.

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.